Business
2 blockbuster blue chip ASX shares to buy in January – The Motley Fool Australia
Here’s why CSL Limited (ASX:CSL) and this blue chip ASX share could be blockbuster buys for investors right now…
If you’re planning to add a few blue chip ASX shares to your portfolio in the near future, then I would suggest you consider the two listed below.
As far as two brokers are concerned, they could be among the best on offer on the Australian share market right now. Here’s why they are rated as buys:
CSL is one of the world’s leading biotherapeutics companies and the name behind the high quality CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies, whereas Seqirus…
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General23 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business18 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM